FindMyKOL
Clinical trialNCT00039156UnknownPhase 2Interventional

BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma

SponsorTheradexLymphoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of BAY 59-8862 in treating patients who have refractory non-Hodgkin's lymphoma.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Cross Cancer Institute

    Edmonton, Alberta, Canada

  • St. Paul'S Hospital - Vancouver

    Vancouver, British Columbia, Canada

United States
  • Mount Sinai Comprehensive Cancer Center

    Miami Beach, Florida, United States

  • University of Chicago Cancer Research Center

    Chicago, Illinois, United States

  • Louisiana State University Health Sciences Center - Shreveport

    Shreveport, Louisiana, United States

  • Veterans Affairs Medical Center - Shreveport

    Shreveport, Louisiana, United States

  • Cancer Institute of New Jersey

    New Brunswick, New Jersey, United States

  • Hemoncare, P.C.

    Brooklyn, New York, United States

  • North Shore University Hospital

    Manhasset, New York, United States

  • State University of New York - Upstate Medical University

    Syracuse, New York, United States

  • Albert Einstein Clinical Cancer Center

    The Bronx, New York, United States

  • New York Medical College

    Valhalla, New York, United States

  • West Clinic

    Memphis, Tennessee, United States

  • Seattle Cancer Care Alliance

    Seattle, Washington, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Ortataxel
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2002
Primary completion
—
Completion
—
Last update posted
24 Jul 2008
Registered enrollment
—
Registry id
NCT00039156

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.